Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,546
Recruiting: 1,932
Ph III recruiting: 225
Growth YoY: +16.4%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 51–100 of 235 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07756008	Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer	not yet recruiting	Phase 2 / Phase 3	114	Tianjin Medical University Second HospitalOTHER	1	Aug 10, 2026	clinicaltrials
NCT07730125	Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies	not yet recruiting	Phase 1 / Phase 2	67	CoRegen, Inc.INDUSTRY	0	Aug 7, 2026